DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Information source: GlaxoSmithKline
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Dyslipidemia; Hypertriglyceridemia

Intervention: GW590735 (Drug); fenofibrate (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: GlaxoSmithKline

Official(s) and/or principal investigator(s):
GSK Clinical Trials, MD, Study Director, Affiliation: GlaxoSmithKline

Summary

An eight week comparison of the investigational drug GW590735, placebo, and the marketed drug fenofibrate intended to increase the levels of "good cholesterol" and decrease levels of "bad cholesterol" in healthy patients with low levels of good cholesterol and high levels of bad cholesterol.

Clinical Details

Official title: A Multi-Center, Three-Staged, Randomized, Parallel Group, Sequential, Double-Blind, Fenofibrate-and Placebo-Controlled Dose-Response Evaluation of the Safety, Tolerability, and Effects on Plasma HDLc and TG of Eight Weeks Treatment With 1µg to 20µg Daily Doses of GW590735 in Otherwise Healthy Subjects With Low HDLc, Mildly to Moderately Elevated TG, and Normal LDLc

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: change from baseline in fasting plasma HDLc concentration at the end of eight weeks of double blind treatment

Secondary outcome: changes from baseline in: fasting plasma total cholesterol, TG, LDLc, ApoA1, ApoA2, Lipoprotein containing ApoA1 and not ApoA2, Lipoprotein containing both ApoA1 and ApoA2, Apo B100, Apo CIII, Free Fatty Acid, insulin, fibrinogen, and C-reactive protein

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion criteria:

- High-density lipoprotein cholesterol less than or equal to 45 mg/dL.

- Triglycerides greater than or equal to 120 mg/dL and less than or equal to 500 mg/dL.

- Women must be surgically sterile or postmenopausal.

Exclusion criteria:

- Heart disease

- Diabetes

Locations and Contacts

GSK Clinical Trials Call Center, Phoenix, Arizona 85014, United States

GSK Clinical Trials Call Center, Beverly Hills, California 90210, United States

GSK Clinical Trials Call Center, Spring Valley, California 91978, United States

GSK Clinical Trials Call Center, Yuba City, California 95991, United States

GSK Clinical Trials Call Center, Walnut Creek, California 94598, United States

GSK Clinical Trials Call Center, Healdsburg, California 95448, United States

GSK Clinical Trials Call Center, Deland, Florida 32720, United States

GSK Clinical Trials Call Center, Hollywood, Florida 33021, United States

GSK Clinical Trials Call Center, Fort Lauderdale, Florida 33308, United States

GSK Clinical Trials Call Center, Jacksonville, Florida 32216, United States

GSK Clinical Trials Call Center, Jacksonville, Florida 32205, United States

GSK Clinical Trials Call Center, Orland Park, Illinois 60462, United States

GSK Clinical Trials Call Center, Indianapolis, Indiana 46260, United States

GSK Clinical Trials Call Center, Evansville, Indiana 47713, United States

GSK Clinical Trials Call Center, Louisville, Kentucky 40213, United States

GSK Clinical Trials Call Center, Erlanger, Kentucky 41017, United States

GSK Clinical Trials Call Center, Auburn, Maine 04210, United States

GSK Clinical Trials Call Center, Arden Hills, Minnesota 55126, United States

GSK Clinical Trials Call Center, Omaha, Nebraska 68131, United States

GSK Clinical Trials Call Center, East Syracuse, New York 13057, United States

GSK Clinical Trials Call Center, New York, New York 10021, United States

GSK Clinical Trials Call Center, Endwell, New York 13760, United States

GSK Clinical Trials Call Center, Rochester, New York 14609, United States

GSK Clinical Trials Call Center, Williamsville, New York 14221, United States

GSK Clinical Trials Call Center, Wilmington, North Carolina 28412, United States

GSK Clinical Trials Call Center, Cincinnati, Ohio 45229, United States

GSK Clinical Trials Call Center, Allentown, Pennsylvania 18103, United States

GSK Clinical Trials Call Center, Bristol, Tennessee 37620, United States

GSK Clinical Trials Call Center, Kingsport, Tennessee 37660, United States

GSK Clinical Trials Call Center, Bryan, Texas 77802, United States

GSK Clinical Trials Call Center, Houston, Texas 77030, United States

GSK Clinical Trials Call Center, Norfolk, Virginia 23502, United States

GSK Clinical Trials Call Center, Richmond, Virginia 23294, United States

Additional Information

Starting date: November 2004
Last updated: September 12, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009